PENG vs Deep Iliacus Plane Block in Intertrochanteric Femur Fractures

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorErzincan Binali Yildirim Universitesi

About this trial

Intertrochanteric femur fractures are common in elderly patients and are associated with significant pain. Providing effective analgesia is clinically important both during positioning for spinal anesthesia and in the postoperative period in this patient population.

The Pericapsular Nerve Group (PENG) block is a regional anesthesia technique that targets the articular branches of the hip capsule and may provide effective analgesia with motor-sparing potential. The Deep Iliacus Plane Block (DIPB) is a newer approach that may spread to both the articular branches and the lateral femoral cutaneous nerve.

Although both blocks are used in patients with intertrochanteric fractures, there is a lack of sufficient randomized controlled data comparing their effectiveness for pain during positioning for spinal anesthesia and for postoperative analgesia. Therefore, it is important to determine which technique provides greater clinical benefit.

The aim of this study is to compare the analgesic efficacy of the PENG block and the Deep Iliacus Plane Block during positioning for spinal anesthesia and in the postoperative period in patients undergoing surgery for intertrochanteric femur fractures.

Eligibility criteria

Qualifiers

Patients scheduled for elective surgery for intertrochanteric femur fractures

Patients with ASA physical status I, II, or III

Patients aged between 30 and 85 years

Disqualifiers

Patients with ASA physical status IV or higher

Patients undergoing emergency surgery

Patients who refuse to participate or withdraw consent during the study

Patients with cognitive dysfunction such as Alzheimer's disease, dementia, or delirium

Trial design

Treatments tested in this trial

  • Intravenous Analgesia
  • Pericapsular nerve group (PENG) block
  • Deep Iliacus Plane Block (DIPB)

Treatment groups

75 Participants
are divided into 3 treatment groups